Bioperfectus Molecular Diagnostic Products Continue to Help Guyana Fight COVID-19 Pandemic

Company news
2021-09-01

With the COVID-19 cases resurging in Guyana, another batch ofBioperfectus Viral Nucleic Acid Extraction Kit (Magnetic Bead Method)were handed over toThe Cooperative Republic of GuyanabyEmbassy of People’s Republic of Chinaon August 24th, 2021.

 

The handover ceremony was attended by Mr. Hon. Dr. Frank C.S. Anthony, Minister of Health Guyana, Mr. Chen Xilai, Chargé d'affaires of the Chinese Embassy, Economic and Commercial Counsellor, Mr. Hu Hanming as well as Medical Aids to Guyana Team representatives.

 

 

 

It is the second donation handover ceremony held between the two sides. Last year,Bioperfectus Nucleic Acid Extraction System as well as extraction kitswere also included in the donation ceremony, which greatly improved the diagnostic capability in the local hospitals and laboratories.

 

 

With proven quality, Bioperfectus Nucleic Acid Extraction Solution plays an important role in the diagnosis of the infectious disease. We Bioperfectus sincerely hope our products will become the solid support for combating the virus in Guyana and we deeply believe that the friendship between China and Guyana will be further strengthened after the storm of the pandemic.

 

References:

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14